3-methoxytyramine has been researched along with Pheochromocytoma, Extra-Adrenal in 35 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Excerpt | Relevance | Reference |
---|---|---|
"Measurements of plasma free metanephrines (MNs), including MN and normetanephrine, provide high sensitivity and specificity for the diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 8.12 | Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. ( Gao, Y; Guo, X; Li, X; Li, Y; Liu, L; Song, Z; Wang, T; Xie, W; Zhang, J, 2022) |
"Accurate diagnosis of pheochromocytoma and paraganglioma (PPGLs) is highly dependent on the detection of metanephrines and catecholamines." | 8.02 | Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. ( Cong, H; Gao, X; Guo, Y; Shi, X; Sun, N; Wang, K; Xie, L; Zhang, W; Zhou, Z, 2021) |
" This study assessed whether urinary-free normetanephrine, metanephrine and methoxytyramine in overnight/first-morning urine collections might offer an alternative to measurements in 24-h collections or plasma for diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 7.96 | Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option? ( Bursztyn, M; Conrad, C; Constantinescu, G; Därr, R; Eisenhofer, G; Fliedner, S; Kaden, D; Langton, K; Lenders, JWM; Pamporaki, C; Peitzsch, M; Prejbisz, A; Sinnott, RO, 2020) |
"The 24 h urinary-fractionated metanephrine (MN) and normetanephrine (NMN) are recommended as the preferred indicators for laboratory diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 7.96 | Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. ( Cong, H; Dai, S; Gao, X; Shi, X; Wang, K; Zhang, W; Zhou, Z, 2020) |
"In patients with phaeochromocytomas or paragangliomas (PPGLs), 24-h urine collections for metanephrines (uMNs) are cumbersome." | 7.96 | Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas. ( Grossman, AB; Isidori, AM; Jafar-Mohammadi, B; James, T; Maunsell, Z; May, CJH; Sbardella, E; Shine, B; Tadman, M, 2020) |
"Detection of normetanephrine (NMN), metanephrine (MN) and 3-methoxytyramine (3-MT) could be used to diagnose pheochromocytomas and paragangliomas (PPGLs)." | 7.96 | Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas. ( Chen, H; Ding, M; Luo, C; Wang, H; Zhang, X; Zhen, Q; Zou, W, 2020) |
"Plasma free metanephrines are commonly used for diagnosis of pheochromocytoma and paraganglioma (PPGLs), but can also provide other information." | 7.96 | Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. ( Bechmann, N; Beuschlein, F; Calsina, B; Constantinescu, G; Deutschbein, T; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Fliedner, S; Langton, K; Lenders, JWM; Monteagudo, M; Nölting, S; Pamporaki, C; Peitzsch, M; Prejbisz, A; Robledo, M; Stell, A; Timmers, HJLM, 2020) |
"Measurements of plasma methoxytyramine, the O-methylated dopamine metabolite, are useful for detecting rare dopamine-producing pheochromocytomas and paragangliomas (PPGLs) and head and neck paragangliomas (HNPGLs), but utility for screening beyond that achieved using standard measurements of normetanephrine and metanephrine is unclear." | 7.85 | Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. ( Beuschlein, F; Brugger, C; Eisenhofer, G; Fassnacht, M; Fliedner, S; Gudziol, V; Hanus, K; Januszewicz, A; Langton, K; Lenders, JWM; Pamporaki, C; Peitzsch, M; Prejbisz, A; Rao, D; Stell, A; Timmers, HJLM, 2017) |
"This work discusses the clinical performance of deconjugated metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3MT) determined in the basal first morning urine using a chromatographic method with electrochemical detection for the clinical diagnosis of pheochromocytoma (PHEO) and paraganglioma (PGL)." | 7.81 | Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma. ( Bešťák, J; Bílek, R; Dušková, J; Michalský, D; Novák, K; Vlček, P; Widimský, J; Zelinka, T, 2015) |
"The effects of an organophosphate (OP) pesticide, fenthion (FEN), on the release and metabolism of dopamine were evaluated in a clonal line of rat pheochromocytoma (PC12) cells." | 7.67 | Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion. ( Bowen, JM; Hazen, AA; Tuler, SM, 1989) |
"Pheochromocytomas are rare catecholamine-producing tumors derived in more than 30% of cases from mutations in 9 tumor-susceptibility genes identified to date, including von Hippel-Lindau tumor suppressor (VHL); succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (SDHB); and succinate dehydrogenase complex, subunit D, integral membrane protein (SDHD)." | 5.37 | Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. ( Adams, K; Bornstein, SR; Bratslavsky, G; Eisenhofer, G; Grebe, SK; Hofbauer, LC; Lenders, JW; Linehan, WM; Mannelli, M; Pacak, K; Tiebel, O; Timmers, H, 2011) |
"Measurements of plasma metanephrines and methoxytyramine provide a sensitive test for diagnosis of pheochromocytoma/paraganglioma." | 4.84 | False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade. ( Biemann, R; Eisenhofer, G; Pamporaki, C; Peitzsch, M; Rayes, N; Rohm, S; Sabri, O; Sandner, B; Schürfeld, R; Tönjes, A, 2024) |
"Measurements of plasma free metanephrines (MNs), including MN and normetanephrine, provide high sensitivity and specificity for the diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 4.12 | Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. ( Gao, Y; Guo, X; Li, X; Li, Y; Liu, L; Song, Z; Wang, T; Xie, W; Zhang, J, 2022) |
"Accurate diagnosis of pheochromocytoma and paraganglioma (PPGLs) is highly dependent on the detection of metanephrines and catecholamines." | 4.02 | Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma. ( Cong, H; Gao, X; Guo, Y; Shi, X; Sun, N; Wang, K; Xie, L; Zhang, W; Zhou, Z, 2021) |
" This study assessed whether urinary-free normetanephrine, metanephrine and methoxytyramine in overnight/first-morning urine collections might offer an alternative to measurements in 24-h collections or plasma for diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 3.96 | Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option? ( Bursztyn, M; Conrad, C; Constantinescu, G; Därr, R; Eisenhofer, G; Fliedner, S; Kaden, D; Langton, K; Lenders, JWM; Pamporaki, C; Peitzsch, M; Prejbisz, A; Sinnott, RO, 2020) |
"The 24 h urinary-fractionated metanephrine (MN) and normetanephrine (NMN) are recommended as the preferred indicators for laboratory diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 3.96 | Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma. ( Cong, H; Dai, S; Gao, X; Shi, X; Wang, K; Zhang, W; Zhou, Z, 2020) |
"In patients with phaeochromocytomas or paragangliomas (PPGLs), 24-h urine collections for metanephrines (uMNs) are cumbersome." | 3.96 | Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas. ( Grossman, AB; Isidori, AM; Jafar-Mohammadi, B; James, T; Maunsell, Z; May, CJH; Sbardella, E; Shine, B; Tadman, M, 2020) |
"Detection of normetanephrine (NMN), metanephrine (MN) and 3-methoxytyramine (3-MT) could be used to diagnose pheochromocytomas and paragangliomas (PPGLs)." | 3.96 | Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas. ( Chen, H; Ding, M; Luo, C; Wang, H; Zhang, X; Zhen, Q; Zou, W, 2020) |
"Plasma free metanephrines are commonly used for diagnosis of pheochromocytoma and paraganglioma (PPGLs), but can also provide other information." | 3.96 | Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. ( Bechmann, N; Beuschlein, F; Calsina, B; Constantinescu, G; Deutschbein, T; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Fliedner, S; Langton, K; Lenders, JWM; Monteagudo, M; Nölting, S; Pamporaki, C; Peitzsch, M; Prejbisz, A; Robledo, M; Stell, A; Timmers, HJLM, 2020) |
"Measurements of plasma methoxytyramine, the O-methylated dopamine metabolite, are useful for detecting rare dopamine-producing pheochromocytomas and paragangliomas (PPGLs) and head and neck paragangliomas (HNPGLs), but utility for screening beyond that achieved using standard measurements of normetanephrine and metanephrine is unclear." | 3.85 | Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. ( Beuschlein, F; Brugger, C; Eisenhofer, G; Fassnacht, M; Fliedner, S; Gudziol, V; Hanus, K; Januszewicz, A; Langton, K; Lenders, JWM; Pamporaki, C; Peitzsch, M; Prejbisz, A; Rao, D; Stell, A; Timmers, HJLM, 2017) |
"This work discusses the clinical performance of deconjugated metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3MT) determined in the basal first morning urine using a chromatographic method with electrochemical detection for the clinical diagnosis of pheochromocytoma (PHEO) and paraganglioma (PGL)." | 3.81 | Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma. ( Bešťák, J; Bílek, R; Dušková, J; Michalský, D; Novák, K; Vlček, P; Widimský, J; Zelinka, T, 2015) |
"Measurements of plasma normetanephrine (NMN) and metanephrine (MN) provide a sensitive test for diagnosis of phaeochromocytomas and paragangliomas (PPGLs), but do not allow detection of dopamine-producing tumours." | 3.79 | Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. ( Arlt, W; Beuschlein, F; Eisenhofer, G; Januszewicz, A; Kroiß, M; Peitzsch, M; Prejbisz, A; Siegert, G, 2013) |
"Measurements of the 3-O-methylated metabolites of catecholamines [metanephrines (MNs)] in plasma or urine are recommended for diagnosis of pheochromocytoma." | 3.75 | Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. ( de Jong, WH; de Vries, EG; Eisenhofer, G; Kema, IP; Muskiet, FA; Post, WJ, 2009) |
"The effects of an organophosphate (OP) pesticide, fenthion (FEN), on the release and metabolism of dopamine were evaluated in a clonal line of rat pheochromocytoma (PC12) cells." | 3.67 | Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion. ( Bowen, JM; Hazen, AA; Tuler, SM, 1989) |
"Pheochromocytoma is a rare neuroendocrine tumor, clinically characterized by high blood pressure, palpitations, and headache." | 1.51 | Electrical Remodeling of Ventricular Repolarization Abnormality after Treatment in Pheochromocytoma: U Wave Finding in a Retrospective Analysis. ( De Luca, G; Di Stolfo, G; Maggio, A; Mastroianno, S; Potenza, DR; Russo, A; Salvatori, MP, 2019) |
"Pheochromocytomas are rare catecholamine-producing tumors derived in more than 30% of cases from mutations in 9 tumor-susceptibility genes identified to date, including von Hippel-Lindau tumor suppressor (VHL); succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (SDHB); and succinate dehydrogenase complex, subunit D, integral membrane protein (SDHD)." | 1.37 | Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. ( Adams, K; Bornstein, SR; Bratslavsky, G; Eisenhofer, G; Grebe, SK; Hofbauer, LC; Lenders, JW; Linehan, WM; Mannelli, M; Pacak, K; Tiebel, O; Timmers, H, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.57) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 15 (42.86) | 24.3611 |
2020's | 12 (34.29) | 2.80 |
Authors | Studies |
---|---|
Liu, L | 1 |
Xie, W | 1 |
Song, Z | 1 |
Wang, T | 1 |
Li, X | 1 |
Gao, Y | 1 |
Li, Y | 1 |
Zhang, J | 1 |
Guo, X | 2 |
Wang, K | 3 |
Gao, X | 2 |
Zhang, W | 2 |
Sun, N | 1 |
Xie, L | 1 |
Cong, H | 2 |
Guo, Y | 1 |
Shi, X | 2 |
Zhou, Z | 2 |
Yu, S | 1 |
Zhou, W | 1 |
Yu, J | 1 |
Li, M | 1 |
Zhang, S | 1 |
Jiang, X | 1 |
Wang, H | 2 |
Ma, X | 1 |
Zou, Y | 1 |
Wang, D | 1 |
Cheng, Q | 1 |
Xie, S | 1 |
Luo, W | 1 |
Qiu, L | 1 |
Pamporaki, C | 7 |
Berends, AMA | 1 |
Filippatos, A | 1 |
Prodanov, T | 1 |
Meuter, L | 1 |
Prejbisz, A | 8 |
Beuschlein, F | 6 |
Fassnacht, M | 4 |
Timmers, HJLM | 3 |
Nölting, S | 2 |
Abhyankar, K | 1 |
Constantinescu, G | 3 |
Kunath, C | 2 |
de Haas, RJ | 1 |
Remde, H | 1 |
Bornstein, SR | 5 |
Januszewicz, A | 6 |
Robledo, M | 2 |
Lenders, JWM | 5 |
Kerstens, MN | 2 |
Pacak, K | 4 |
Eisenhofer, G | 15 |
Schürfeld, R | 1 |
Peitzsch, M | 10 |
Rayes, N | 1 |
Sabri, O | 1 |
Rohm, S | 1 |
Biemann, R | 1 |
Sandner, B | 1 |
Tönjes, A | 1 |
Kaden, D | 1 |
Langton, K | 3 |
Conrad, C | 1 |
Fliedner, S | 3 |
Sinnott, RO | 1 |
Därr, R | 2 |
Bursztyn, M | 1 |
Dai, S | 1 |
Sbardella, E | 1 |
Maunsell, Z | 1 |
May, CJH | 1 |
Tadman, M | 1 |
James, T | 1 |
Jafar-Mohammadi, B | 1 |
Isidori, AM | 1 |
Grossman, AB | 1 |
Shine, B | 1 |
Zhang, X | 1 |
Zhen, Q | 1 |
Zou, W | 1 |
Chen, H | 1 |
Luo, C | 1 |
Ding, M | 1 |
Deutschbein, T | 1 |
Calsina, B | 1 |
Monteagudo, M | 1 |
Bechmann, N | 1 |
Fankhauser, M | 1 |
Stell, A | 3 |
Jian, M | 1 |
Huang, H | 1 |
Li, K | 1 |
Chuan, L | 1 |
Li, L | 1 |
Jiang, L | 1 |
Małecki, R | 1 |
Pistrosch, F | 1 |
Bishoff, S | 1 |
Mueller, P | 1 |
Meyer, I | 1 |
Reimann, D | 1 |
Hanus, K | 2 |
Parmentier, S | 1 |
Passauer, J | 1 |
Rao, D | 1 |
Brugger, C | 1 |
Gudziol, V | 1 |
Mangelis, A | 1 |
Huebner, A | 1 |
Chtioui, H | 1 |
Sadowski, SM | 1 |
Winzeler, B | 1 |
Tschopp, O | 1 |
Grouzmann, E | 1 |
Abid, K | 1 |
Di Stolfo, G | 1 |
Mastroianno, S | 1 |
Maggio, A | 1 |
De Luca, G | 1 |
Potenza, DR | 1 |
Salvatori, MP | 1 |
Russo, A | 1 |
Kroiß, M | 1 |
Arlt, W | 1 |
Siegert, G | 3 |
Brown, S | 1 |
Pelzel, D | 1 |
Lattke, P | 1 |
Glöckner, S | 1 |
Reichmann, H | 1 |
Miehle, K | 1 |
Peczkowska, M | 1 |
Weismann, D | 1 |
Sinnott, R | 1 |
Neumann, HP | 1 |
Lenders, J | 1 |
van Berkel, A | 1 |
Lenders, JW | 3 |
Timmers, HJ | 2 |
Garcia Hejl, C | 1 |
Dedome, E | 1 |
Chianea, D | 1 |
Ramirez Martinez, J | 1 |
Vest, P | 1 |
Osinga, TE | 1 |
Korpershoek, E | 1 |
de Krijger, RR | 1 |
Dullaart, RP | 1 |
Kema, IP | 3 |
van der Laan, BF | 1 |
van der Horst-Schrivers, AN | 1 |
Links, TP | 1 |
Bílek, R | 1 |
Zelinka, T | 1 |
Vlček, P | 1 |
Dušková, J | 1 |
Michalský, D | 1 |
Novák, K | 1 |
Bešťák, J | 1 |
Widimský, J | 1 |
Patin, F | 1 |
Crinière, L | 1 |
Francia, T | 1 |
Kassem, S | 1 |
Pierre, P | 1 |
Bruno, C | 1 |
Vayne, C | 1 |
Vourc'h, P | 1 |
Benz-de Bretagne, I | 1 |
Andres, CR | 1 |
Blasco, H | 1 |
de Jong, WH | 1 |
Post, WJ | 1 |
Muskiet, FA | 1 |
de Vries, EG | 1 |
Timmers, H | 1 |
Mannelli, M | 2 |
Grebe, SK | 1 |
Hofbauer, LC | 1 |
Tiebel, O | 1 |
Adams, K | 2 |
Bratslavsky, G | 1 |
Linehan, WM | 2 |
Friberg, P | 1 |
Milosevic, D | 1 |
Serra, PA | 1 |
Rocchitta, G | 1 |
Delogu, MR | 1 |
Migheli, R | 1 |
Taras, MG | 1 |
Mura, MP | 1 |
Esposito, G | 1 |
Miele, E | 1 |
Desole, MS | 1 |
Miele, M | 1 |
Goldstein, DS | 1 |
Sullivan, P | 1 |
Csako, G | 1 |
Brouwers, FM | 1 |
Lai, EW | 1 |
Adams, KT | 1 |
Buu, NT | 1 |
Angers, M | 1 |
Chevalier, D | 1 |
Kuchel, O | 1 |
Jouve, J | 1 |
Mariotte, N | 1 |
Sureau, C | 1 |
Muh, JP | 1 |
Proye, C | 1 |
Racadot-Leroy, N | 1 |
Vix, M | 1 |
Vermesse, B | 1 |
Carnaille, B | 1 |
Willemsen, JJ | 1 |
Ross, HA | 1 |
Wolthers, BG | 1 |
Sweep, CG | 1 |
Tuler, SM | 1 |
Hazen, AA | 1 |
Bowen, JM | 1 |
2 reviews available for 3-methoxytyramine and Pheochromocytoma, Extra-Adrenal
Article | Year |
---|---|
Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Catecholamines; Dopamine; False Negative Reaction | 2014 |
Laboratory evaluation of pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Clinical Laboratory Techniques; Dopamine; Humans; Metanephrine; Normetaneph | 2014 |
2 trials available for 3-methoxytyramine and Pheochromocytoma, Extra-Adrenal
Article | Year |
---|---|
Optimized procedures for testing plasma metanephrines in patients on hemodialysis.
Topics: Adrenal Gland Neoplasms; Aged; Aged, 80 and over; Blood Chemical Analysis; Blood Specimen Collection | 2021 |
Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blood Specim | 2014 |
31 other studies available for 3-methoxytyramine and Pheochromocytoma, Extra-Adrenal
Article | Year |
---|---|
Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
Topics: Adrenal Gland Neoplasms; Chromogranin A; Dopamine; Humans; Metanephrine; Paraganglioma; Pheochromocy | 2022 |
Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Anticoagulants; Catecholamines; Dopamine; Epinephrine; Hemoglobins; Humans; | 2021 |
An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry.
Topics: Adrenal Gland Neoplasms; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dopamine; Hum | 2022 |
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
Topics: Adrenal Gland Neoplasms; Cross-Sectional Studies; Humans; Machine Learning; Paraganglioma; Pheochrom | 2023 |
False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
Topics: Adrenal Gland Neoplasms; Antidepressive Agents, Tricyclic; Humans; Metanephrine; Norepinephrine; Nor | 2024 |
Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biomarkers; Dopamine; Female; H | 2020 |
Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Chromatography, Liquid; Dopamine; Female; Humans; Male; Metanephrine; Norme | 2020 |
Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; | 2020 |
Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
Topics: Adrenal Gland Neoplasms; Chromatography, High Pressure Liquid; Cohort Studies; Dopamine; Humans; Lim | 2020 |
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Dopamine; Fe | 2020 |
A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency.
Topics: Adrenal Gland Neoplasms; Calibration; Catecholamines; Chromatography, Liquid; Dopamine; Female; Huma | 2021 |
Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biomarkers; Child; Dopamine; Fe | 2017 |
Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Topics: Adolescent; Adrenal Gland Neoplasms; Aging; Blood Chemical Analysis; Catecholamines; Child; Child, P | 2019 |
High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy?
Topics: Adrenal Gland Neoplasms; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Dopamine; Dopam | 2019 |
Electrical Remodeling of Ventricular Repolarization Abnormality after Treatment in Pheochromocytoma: U Wave Finding in a Retrospective Analysis.
Topics: Adrenal Gland Neoplasms; Adult; Dopamine; Electrocardiography; Female; Heart Diseases; Humans; Male; | 2019 |
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Chemical Analysis; Chromatography, High Pressure Liquid; | 2013 |
Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Topics: Aged; Aged, 80 and over; Chromatography, Liquid; Dopamine; Epinephrine; Female; Humans; Levodopa; Ma | 2014 |
Pheochromocytoma: yes or no?
Topics: Adrenal Gland Neoplasms; Aged; Diagnosis, Differential; Dopamine; Female; Humans; Pheochromocytoma | 2014 |
Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.
Topics: Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Dopamine beta-Hydroxylase; Female; Head and Neck Neo | 2015 |
Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Clinical Lab | 2015 |
Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas.
Topics: Adrenal Gland Neoplasms; Dopamine; Humans; Paraganglioma; Pheochromocytoma; Retrospective Studies | 2016 |
Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Diet; Dopamine; Female; | 2009 |
Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Diagnosis, Differential; Dopamine; Humans; Metanephrine; | 2011 |
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Dopamine; Female; Humans; Male; Middle Aged; Muta | 2012 |
Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Calcium; Calcium Channel Blockers; Cell Surv | 2003 |
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
Topics: Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Middle Aged; | 2005 |
A new method for the simultaneous analysis of free and sulfoconjugated normetanephrine, metanephrine, and 3-methoxytyramine in human urine by HPLC with electrochemical detection.
Topics: Adrenal Gland Neoplasms; Adult; Chromatography, High Pressure Liquid; Dopamine; Epinephrine; Female; | 1984 |
High-performance liquid chromatography with electrochemical detection for the simultaneous determination of the methoxylated amines, normetanephrine, metanephrine and 3-methoxytyramine, in urine.
Topics: Adolescent; Adult; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dopamine; Electroc | 1983 |
[Comparative secretory profiles of benign and malignant pheochromocytomas].
Topics: Adrenal Gland Neoplasms; Dopamine; Epinephrine; Humans; Norepinephrine; Pheochromocytoma | 1994 |
Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Chromatography, High Pressure Liquid; Dopamine; Electrochemist | 2001 |
Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Gland Neoplasms; Animals; Dopamine; Fenthion; Homovanillic A | 1989 |